Nov. 20 - University Innovation Symposium

November 20, 2010 from 8:30 A.M. until 6:30 P.M.

Symposium Location: 

American University, Washington College of Law, Room 603
4801 Massachusetts Ave., NW Washington, DC 20016

PIJIP and Universities Allied for Essential Medicines will cohost this symposium for NGO representatives, university professors and administrators, and policy makers to focus on strategies to increase research on neglected diseases and innovative policies for universities to contribute most effectively to the medicines innovation system. Topics will include intellectual property protection, licensing, and alternate models of funding.

Click here to register - select the drop down and scroll to "Nov. 20 Workshop on Neglected Diseases"

Click here for UAEM Symposium Website

Agenda (updated October 5, 2010)

Universities are increasingly integrated into the pharmaceutical innovation system. Institutions such as Yale and the University of British Columbia, for instance, now have their own high through-put screening facilities, traditionally controlled only by industry, which allow them to do rapid tests of thousands of molecules in their compound libraries to screen for potential new drug targets.  Yale has taken this a step further by purchasing a facility from pharmaceutical company Bayer in order to quicken the pace and scope of its biomedical research capabilities. 

Universities are also engaging increasingly with product development partnerships product development partnerships (PDPs) such as DNDi to aid them in finding cures for diseases of the poor.  Combined with the trend toward open access publishing standards for academic papers at many schools, universities are well placed to accelerate the ability of researchers to find life-saving discoveries. 

In order to address and further explore these possibilities, UAEM is holding a symposium on the role of universities as non-profit institutions in the medicine innovation system, particularly related to their role in finding cures for neglected diseases as well as open-source research methods. 

The meeting will bring together product development partnerships (PDPs), university administrators, researchers, industry actors, technology transfer officials, funding institutions and students to explore the role of universities in the broader innovation system and directions for university policy to best improve both innovation and access to medicines. 

We hope you can join us as we gather in Washington, D.C., on November 20, 2010 from 8:30 A.M to 6:30 P.M.

Please continue to check back at this site for the most updated information regarding the conference. We look forward to seeing you in November.

The symposium is made possible by the kind support of the Perls Foundation

Confirmed Speakers and Participants include

Rohit Malpani, Oxfam

Bhaven Sampat, Columbia University 

Gloria Tavera, NIH Research Fellow, UAEM

Kishor Wasan, University of British Columbia

Rita Khanna, Aeras Global TB Vaccine Foudation

Sandeep Kishore, Weill-Cornell Medical College, UAEM

James Love, Director, Knowledge Ecology International

Paul Wilson, Assistant Professor of Clinical Population and Family Health , Columbia University

Pamela Small, University of Tennessee

Zakir Thomas, Open Source Drug Discovery Network, India

Heather Joseph, Executive Director, SPARC

Rebecca Goulding, Open Health Initiative 

Matt Todd, The Synaptic Leap, Australia

Dr. Tom Wellems, National Institute of Allergy and Infectious Disease

Rachel Kiddell-MonroeUniversities Allied for Essential Medicines


Image of Pills (cc) Fillmore Photography.


Permalink :